Drug Trial Radar · NCT07088068
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
723
Planned (sponsor's estimate)
Start
Aug 6, 2025
Primary completion
Jun 6, 2028
Study completion Dec 12, 2028
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- First posted
- Jul 28, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 1 year, up to 25 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase 3, 2-arm study for treatment. The purpose of this study is to measure change in glycemic control and prandial insulin independency over 52 weeks with teplizumab compared with placebo, both administered by intravenous (IV) infusion, in participants with recently diagnosed Stage 3 type 1 diabetes (T1D) aged 1 to 25 years, on standard insulin therapy.
Conditions
- Type 1 Diabetes Mellitus
Interventions
TeplizumabDrug
Pharmaceutical form: Concentrated solution for infusion Route of administration: Intravenous infusion
PlaceboOther
Pharmaceutical form: Concentrated solution for infusion Route of administration: Intravenous infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- For United States (US) and non-European Union (EU) countries: Glycated hemoglobin (HbA1c) change from baselineTime frame: From Baseline to Week 52
- For US and non-EU countries: Total number of days without prandial insulin useTime frame: From baseline to Week 52
- For EU countries: Change from baseline in mean 2 hours mixed meal tolerance test (MMTT) stimulated C-peptide concentration, calculated from Area Under the Curve (AUC) in participants 5 years and olderTime frame: From baseline to Week 52
- For EU countries: HbA1c change from baselineTime frame: From baseline to Week 52
- For EU countries: Total number of days without prandial insulin useTime frame: From baseline to Week 52
Locations
201 sites in 20 countries. Site status is shown where the registry gives one.
Scottsdale Clinical Trials- Site Number : 8400044
Scottsdale, Arizona · Recruiting
Rady Children's Hospital- Site Number : 8400002
San Diego, California · Recruiting
University of California San Francisco - Mission Bay- Site Number : 8400011
San Francisco, California · Recruiting
Barbara Davis Center for Childhood Diabetes- Site Number : 8400031
Aurora, Colorado · Recruiting
Yale University School of Medicine- Site Number : 8400005
New Haven, Connecticut · Recruiting
University of Florida College of Medicine- Site Number : 8400054
Gainesville, Florida · Recruiting
Encore Medical Research - Hollywood- Site Number : 8400061
Hollywood, Florida · Recruiting
Nemours Children's Speciality Care- Jacksonville- Site Number : 8400040
Jacksonville, Florida · Recruiting
University of South Florida- Site Number : 8400013
Tampa, Florida · Recruiting
AdventHealth Winter Park- Site Number : 8400033
Winter Park, Florida · Recruiting
Atlanta Diabetes Associates- Site Number : 8400036
Atlanta, Georgia · Recruiting
Children's Healthcare of Atlanta - Egleston Hospital- Site Number : 8400065
Atlanta, Georgia · Recruiting
IACT Health - Columbus - Talbotton Road- Site Number : 8400003
Columbus, Georgia · Recruiting
St. Luke's Children's Hospital- Site Number : 8400014
Boise, Idaho · Recruiting
Rocky Mountain Clinical Research - Idaho Falls- Site Number : 8400001
Idaho Falls, Idaho · Recruiting
Norton Children's Research Institute - Wendy Novak Diabetes Institute- Site Number : 8400016
Louisville, Kentucky · Recruiting
C.S. Mott Children's Hospital- Site Number : 8400015
Ann Arbor, Michigan · Recruiting
Mayo Clinic in Rochester - Minnesota- Site Number : 8400019
Rochester, Minnesota · Recruiting
Park Nicollet Institute - Oncology Research- Site Number : 8400059
Saint Louis Park, Minnesota · Recruiting
Children's Mercy Adelle Hall Campus- Site Number : 8400010
Kansas City, Missouri · Recruiting
University At Buffalo - Jacobs School Of Medicine- Site Number : 8400006
Buffalo, New York · Recruiting
Endocrine Associates of West Village- Site Number : 8400064
New York, New York · Recruiting
Columbia University Irving Medical Center- Site Number : 8400009
New York, New York · Recruiting
Asheville Clinical Research- Site Number : 8400045
Asheville, North Carolina · Recruiting
UNC Children's Hospital- Site Number : 8400034
Chapel Hill, North Carolina · Recruiting
Cincinnati Children's Hospital Medical Center- Site Number : 8400018
Cincinnati, Ohio · Recruiting
The Ohio State University- Site Number : 8400051
Columbus, Ohio · Recruiting
The Children's Hospital of Philadelphia- Site Number : 8400039
Philadelphia, Pennsylvania · Recruiting
AM Diabetes & Endocrinology Center- Site Number : 8400004
Bartlett, Tennessee · Recruiting
Baylor College of Medicine- Site Number : 8400057
Houston, Texas · Recruiting
University of Utah Health Hospital- Site Number : 8400052
Salt Lake City, Utah · Recruiting
Uva Children's Battle Building- Site Number : 8400060
Charlottesville, Virginia · Recruiting
Benaroya Research Institute at Virginia Mason- Site Number : 8400038
Seattle, Washington · Recruiting
MultiCare Mary Bridge Children's Health Center- Site Number : 8400037
Tacoma, Washington · Recruiting
Investigational Site Number : 0320005
Buenos Aires, Argentina · Recruiting
Investigational Site Number : 0320013
Córdoba, Argentina · Recruiting
Investigational Site Number : 0320002
Salta, Argentina · Recruiting
Investigational Site Number : 0320012
Santa Fe, Argentina · Recruiting
Investigational Site Number : 0320008
Mar del Plata, Buenos Aires, Argentina · Recruiting
Investigational Site Number : 0320003
San Miguel de Tucumán, Tucumán Province, Argentina · Recruiting
Showing 40 of 201 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.